Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Novel Biomarkers of Hypoxia and Metabolism in Clear Cell Renal Cell Carcinoma

NCT05214885 is registered in ClinicalTrials.gov with Qianfoshan Hospital as lead sponsor.

NCT NCT05214885
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05214885 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Novel Biomarkers of Hypoxia and Metabolism in Clear Cell Renal Cell Carcinoma
Lead sponsor
Qianfoshan Hospital
Phase
Observational
Overall status
Recruiting
Start date
February 11, 2022
Completion date
December 31, 2026
Enrollment
300 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

clear cell renal cell carcinoma